Company / Revenue per Share
ANAPTYSBIO, INC Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$7.70
FY2025
5-year range
$0.29 / $7.70
FY2021-FY2025
Trend
+124.3%
vs FY2024
Sector context
#54 of 154
Health Care
What the data says
At $7.70, ANAPTYSBIO, INC's revenue per share ranks #54 of 154 in the Health Care sector. Revenue per Share has fluctuated over the past 10 years, ranging from $0.18 in FY2020 to $7.70 in FY2025.
Based on SEC 10-K filings.
7.70 in FY2025 with a 5-year CAGR of +111.1%.
Improved from $0.60 to $7.70 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +41.6%
- 5-Year CAGR
- +111.1%
- 10-Year CAGR
- -
Sector benchmark
#54 of 154 in Health CareTop 35% of 154This company $7.70 Sector average $15.09
▼
-49.0% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 124.3% year-over-year.
- Ranks #54 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.70 | +124.3% |
| FY2024 | $3.43 | +470.4% |
| FY2023 | $0.60 | -77.8% |
| FY2022 | $2.71 | +827.6% |
| FY2021 | $0.29 | +59.4% |
| FY2020 | $0.18 | -50.6% |
| FY2019 | $0.37 | +83.3% |
| FY2018 | $0.20 | -96.9% |
| FY2017 | $6.63 | +4.8% |
| FY2016 | $6.33 | -8.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026